Literature DB >> 9517614

Airway inflammation in young marijuana and tobacco smokers.

M D Roth1, A Arora, S H Barsky, E C Kleerup, M Simmons, D P Tashkin.   

Abstract

Forty healthy young subjects, ages 20 to 49 yr, underwent videobronchoscopy, mucosal biopsy, and bronchial lavage to evaluate the airway inflammation produced by habitual smoking of marijuana and/or tobacco. Videotapes were graded in a blinded manner for central airway erythema, edema, and airway secretions using a modified visual bronchitis index. The bronchitis index scores were significantly higher in marijuana smokers (MS), tobacco smokers (TS), and in combined marijuana/tobacco smokers (MTS), than in nonsmokers (NS). As a pathologic correlate, mucosal biopsies were evaluated for the presence of vascular hyperplasia, submucosal edema, inflammatory cell infiltrates, and goblet cell hyperplasia. Biopsies were positive for two of these criteria in 97% of all smokers and for three criteria in 72%. By contrast, none of the biopsies from NS exhibited greater than one positive finding. Finally, as a measure of distal airway inflammation, neutrophil counts and interleukin-8 (IL-8) concentrations were determined in bronchial lavage fluid. The percentage of neutrophils correlated with IL-8 levels and exceeded 20% in 0 of 10 NS, 1 of 9 MS, 2 of 9 TS, and 5 of 10 MTS. We conclude that regular smoking of marijuana by young adults is associated with significant airway inflammation that is similar in frequency, type, and magnitude to that observed in the lungs of tobacco smokers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9517614     DOI: 10.1164/ajrccm.157.3.9701026

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  47 in total

Review 1.  Improving the quality of the cannabis debate: defining the different domains.

Authors:  J Strang; J Witton; W Hall
Journal:  BMJ       Date:  2000-01-08

2.  Comparing cannabis with tobacco.

Authors:  John A Henry; William L G Oldfield; Onn Min Kon
Journal:  BMJ       Date:  2003-05-03

3.  Effects of quitting cannabis on respiratory symptoms.

Authors:  Robert J Hancox; Hayden H Shin; Andrew R Gray; Richie Poulton; Malcolm R Sears
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

Review 4.  Biomarkers to assess the utility of potential reduced exposure tobacco products.

Authors:  Dorothy K Hatsukami; Neal L Benowitz; Stephen I Rennard; Cheryl Oncken; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2006-08       Impact factor: 4.244

5.  Pathways from earlier marijuana use in the familial and non-familial environments to self-marijuana use in the fourth decade of life.

Authors:  Judith S Brook; Chenshu Zhang; Jonathan Koppel; David W Brook
Journal:  Am J Addict       Date:  2008 Nov-Dec

6.  Does smoking marijuana increase the risk of chronic obstructive pulmonary disease?

Authors:  Donald P Tashkin
Journal:  CMAJ       Date:  2009-04-14       Impact factor: 8.262

Review 7.  Cannabis Smoking in 2015: A Concern for Lung Health?

Authors:  Jason R Biehl; Ellen L Burnham
Journal:  Chest       Date:  2015-09       Impact factor: 9.410

8.  The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and Nutrition Examination Study.

Authors:  Jordan A Kempker; Eric G Honig; Greg S Martin
Journal:  Ann Am Thorac Soc       Date:  2015-02

9.  Hospital readmissions with exacerbation of obstructive pulmonary disease in illicit drug smokers.

Authors:  Rajesh Yadavilli; Andrea Collins; Wern Yew Ding; Nicola Garner; Janet Williams; Hassan Burhan
Journal:  Lung       Date:  2014-08-06       Impact factor: 2.584

10.  Effects of smoking cessation on airflow obstruction and quality of life in asthmatic smokers.

Authors:  An-Soo Jang; Sung-Woo Park; Do-Jin Kim; Sootaek Uh; Young Hoon Kim; Hun Gyu Whang; Gun Il Lim; Choon-Sik Park
Journal:  Allergy Asthma Immunol Res       Date:  2010-09-06       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.